|Mr. Ayub K. Khattak||Co-Founder, CEO & Chairman||535.62k||N/A||1985|
|Mr. Clint Sever||Co-Founder & Chief Product Officer||733.72k||N/A||1985|
|Mr. Christopher K. Achar||Chief Strategy Officer & Director||N/A||N/A||1985|
|Mr. John E. Gallagher||Chief Financial Officer||N/A||N/A||1973|
|Mr. David Arida||Chief Operating Officer||N/A||N/A||N/A|
|Ms. Erica Palsis Esq.||Gen. Counsel||N/A||N/A||1985|
|Ms. Dena Cook||Chief Communications Officer||N/A||N/A||N/A|
|Mr. Glenn Wada||Chief Commercial Officer||N/A||N/A||N/A|
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for public sectors, healthcare providers, large enterprises, and individual consumers. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System comprising a portable and reusable reader (Cue Reader), a single-use test cartridge (Cue Cartridge), and a sample collection wand (Cue Wand); Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows for integrations with third-party applications and sensors. Its diagnostic test for use with Cue Health Monitoring System is Cue COVID-19 Test Kit for ribonucleic acid of SARS-CoV-2, the virus that causes COVID-19. The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Cue Health Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.